ES8607225A1 - Procedimiento para la obtencion de 6-cetoprostaglandinas conteniendo azufre - Google Patents

Procedimiento para la obtencion de 6-cetoprostaglandinas conteniendo azufre

Info

Publication number
ES8607225A1
ES8607225A1 ES539648A ES539648A ES8607225A1 ES 8607225 A1 ES8607225 A1 ES 8607225A1 ES 539648 A ES539648 A ES 539648A ES 539648 A ES539648 A ES 539648A ES 8607225 A1 ES8607225 A1 ES 8607225A1
Authority
ES
Spain
Prior art keywords
atoms
alkyl
substituted
bond
effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES539648A
Other languages
English (en)
Other versions
ES539648A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES539648A0 publication Critical patent/ES539648A0/es
Publication of ES8607225A1 publication Critical patent/ES8607225A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 6-CETOPROSTAGLANDINAS CONTENIENDO AZUFRE. CONSISTE EN: HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UNO DE FORMULA (III), C30J A 0JC, EN ALCOHOLES O ETERES, COMO DISOLVENTES, Y EN PRESENCIA DE UN CATALIZADOR BASICO, COMO HIDROXIDOS DE METAL ALCALINO O ALCALINO-TERREO, ALCOHOLATOS DE METAL ALCALINO Y OTROS, EN ATMOSFERA DE NITROGENO, PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SUS SALES FISIOLOGICAMENTE COMPATIBLES. SIENDO: D, ALQUILENO DE C 1 A 3, Y OTROS; M, H, O EQUIVALENTE DE UN CATION; R1, H, ALQUILO DE C 1 A 4 Y OTROS; R2, ALQUILO DE C 1 A 7, Y OTROS; R3 Y R4, H, ALQUILO DE C 1 A 7, Y OTROS; R5, H, O ALQUILO DE C 1 A 3; M, POSICION B; N, POSICION A. SE UTILIZAN EN FARMACOLOGIA COMO HIPOPRESORES SANGUINEOS Y COMO INHIBIDORES DE LA AGREGACION DE TROMBOCITOS.
ES539648A 1984-01-18 1985-01-17 Procedimiento para la obtencion de 6-cetoprostaglandinas conteniendo azufre Expired ES8607225A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843401542 DE3401542A1 (de) 1984-01-18 1984-01-18 Schwefelhaltige 6-ketoprostaglandine

Publications (2)

Publication Number Publication Date
ES539648A0 ES539648A0 (es) 1986-05-16
ES8607225A1 true ES8607225A1 (es) 1986-05-16

Family

ID=6225229

Family Applications (1)

Application Number Title Priority Date Filing Date
ES539648A Expired ES8607225A1 (es) 1984-01-18 1985-01-17 Procedimiento para la obtencion de 6-cetoprostaglandinas conteniendo azufre

Country Status (11)

Country Link
US (1) US4680288A (es)
EP (1) EP0150461B1 (es)
JP (1) JPS60161967A (es)
AT (1) ATE33248T1 (es)
AU (1) AU570532B2 (es)
CA (1) CA1251788A (es)
DE (2) DE3401542A1 (es)
ES (1) ES8607225A1 (es)
HU (1) HU192661B (es)
IE (1) IE850109L (es)
ZA (1) ZA85397B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3569728D1 (en) * 1984-03-05 1989-06-01 Teijin Ltd 7-thiaprostaglandin e 1?'s and process for their preparation
DE3533576A1 (de) * 1985-09-20 1987-03-26 Merck Patent Gmbh Cyclopentanderivate
DE3620442A1 (de) * 1986-06-18 1987-12-23 Merck Patent Gmbh Ketolactone
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
GB9011588D0 (en) * 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
AU2003224244A1 (en) * 2002-03-27 2003-10-13 Rosanto Pharmaceuticals Ltd Improvements in pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH612933A5 (es) * 1972-11-17 1979-08-31 Merck Patent Gmbh
DE2422924A1 (de) * 1974-05-11 1975-11-27 Merck Patent Gmbh Thiaprostaglandine
DE2550004C2 (de) * 1975-11-07 1984-04-26 Merck Patent Gmbh, 6100 Darmstadt Thiaprostaglandine sowie Verfahren zu ihrer Herstellung
DE2644972C2 (de) * 1976-10-06 1986-06-19 Merck Patent Gmbh, 6100 Darmstadt Thiaprostansäurederivate, deren Herstellung und diese Verbindungen enthaltende Mittel
US4205178A (en) * 1976-12-30 1980-05-27 The Upjohn Company 6-Keto prostaglandin E-type compounds
JPS6022710B2 (ja) * 1977-09-16 1985-06-03 小野薬品工業株式会社 プロスタグランジン類似化合物
DE2913856A1 (de) * 1979-04-06 1980-10-23 Hoechst Ag Neue prostaglandinderivate in der 6-keto-pge tief 1 -reihe
DE2946116A1 (de) * 1979-11-15 1981-05-27 Hoechst Ag, 6000 Frankfurt Neue prostaglandinderivate in der 6-keto-pga(pfeil abwaerts)1 -reihe(pfeil abwaerts)

Also Published As

Publication number Publication date
DE3401542A1 (de) 1985-08-01
EP0150461A2 (de) 1985-08-07
CA1251788A (en) 1989-03-28
US4680288A (en) 1987-07-14
HU192661B (en) 1987-06-29
HUT39156A (en) 1986-08-28
IE850109L (en) 1985-07-18
AU570532B2 (en) 1988-03-17
ATE33248T1 (de) 1988-04-15
EP0150461A3 (en) 1985-08-21
DE3470159D1 (en) 1988-05-05
ES539648A0 (es) 1986-05-16
ZA85397B (en) 1985-09-25
JPS60161967A (ja) 1985-08-23
EP0150461B1 (de) 1988-03-30
AU3776685A (en) 1985-07-25

Similar Documents

Publication Publication Date Title
FI864614A (fi) Nya difosfonsyraderivat, foerfaranden foer framstaellning av dessa samt laekemedel innehaollande dessa foereningar.
BE898778A (fr) Vinylcephalosporines substituees
IT1152261B (it) Macchina per l'assemblaggio automatico di parti componenti
ES8607225A1 (es) Procedimiento para la obtencion de 6-cetoprostaglandinas conteniendo azufre
KR860004986A (ko) 중합성 티오에스테르 상승제 조성물
AU564667B2 (en) 5 (or 3- amino-6-)substituted phenyl)-2, 3 or (2,5)- dihydro-3 (or5)-imoni-2 alkyl 1, 2, 4 triazine
MY101482A (en) Organophosphorus compound, process for its preparation and insecticidal, miticidal or nematicidal composition containing it
DK44888A (da) Natriumsalt af 5-chlor-3-(2-thenoyl)-2-oxindol-1-carboxamid
IT8521501A0 (it) Procedimento di preparazione di un composto dell'acido 7-amminocefalosporanico.
PT93485A (pt) Processo de preparacao de derivados de 1h,3h-pirrolo{1,2-c}tiazol-7-carboxamida e de composicoes farmaceuticas que os contem
ATE20747T1 (de) Schwefelhaltige indolderivate.
ES8601151A1 (es) Procedimiento para la obtencion de derivados de fenilsulfonil-isotiourea sustituidos de efecto herbicida
ZA858041B (en) Pyridinderivatives
FR2552083B1 (fr) Derives de (alkynyloxy-3 hydroxy-2-propyl)-4 piperazinyl-1 n-phenyl acetamide, leur preparation et leur application en therapeutique
ES8504822A1 (es) Procedimiento para la preparacion de un nuevo derivado del pirrolo ortocondensado
FI850969A0 (fi) Monosilylerade aminofenyletylaminderivat, foerfarande foer deras framstaellning och deras anvaendning vid befraemjandet av tillvaext.
IT8621580A1 (it) Indurimento mediante irradiazione di composti polimerizzabili cationicamente
IT8323139A0 (it) Caviglia per l'assemblaggio di parti di mobili.
DK436284A (da) Salte af antimalariaphenanthrenmethanolforbindelser
ATE56005T1 (de) Pyridinderivate.
IT1153160B (it) Sali dell'ascido 5-(4clorobenzoil)-1,4 dimetil-2-pirrolacetico
ES2052824T3 (es) Procedimiento para la produccion de halosilanos.
PH24449A (en) Substituted 2-furanyl or 5-oxo-2-furanyl methoxy phosphoryl alkyl cyclimmonium salts
SE8300994D0 (sv) Borlegeringstillsats jemte sett for kontinuerlig gjutning av borstal
RO91133A2 (ro) Compozitie de ingrasamint tip suspensie